Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615000591550
ACTRN12615000591550
Recruiting
未知

eurodevelopment of the preterm infant

Professor Paul Colditz0 sites237 target enrollmentJune 5, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBrain development in preterm infantsPrematurityNeurological - Other neurological disordersReproductive Health and Childbirth - Complications of newborn

Overview

Phase
未知
Intervention
Not specified
Conditions
Brain development in preterm infants
Sponsor
Professor Paul Colditz
Enrollment
237
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 5, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Professor Paul Colditz

Eligibility Criteria

Inclusion Criteria

  • •PRETERM GROUP
  • •Infants born at less than 31 weeks gestational age
  • •English speaking family
  • •Live within 200km of either the Royal Brisbane and Women's Hospital or Monash Medical Centre
  • •Have no congenital or chromosomal abnormality that would impact their development
  • •TERM REFERENCE GROUP
  • •Infants born between 38 and 41 weeks postmenstrual age
  • •English speaking family
  • •Live within 200km of either the Royal Brisbane and Women's Hospital or Monash Medical Centre
  • •Have no congenital or chromosomal abnormality that would impact their development

Exclusion Criteria

  • •PRETERM GROUP
  • •Infants born at greater than 31 weeks gestational age
  • •Non English\-speaking family
  • •Live \>200 km from the Royal Brisbane and Women's Hospital or Monash Medical Centre
  • •Have a congenital or chromosomal abnormality that would impact their development
  • •TERM REFERENCE GROUP
  • •Infants born at less than 38 weeks gestational age
  • •Non English\-speaking family
  • •Live \>200 km from the Royal Brisbane and Women's Hospital or Monash Medical Centre
  • •Have a congenital or chromosomal abnormality that would impact their development

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Development of (moderately) preterm infants: regulation skills, parent-infant interaction and parental emotions.Prematurity100422581002892010012562
NL-OMON31497niversiteit van Tilburg500
Not yet recruiting
Not Applicable
eurodevelopment of children born with Preterm and Low Birth Weight at 3 years of age in Belagavi City
CTRI/2024/07/071284Sinchana
Completed
Not Applicable
eurodevelopment of babies born to mothers with epilepsy studySpecialty: Reproductive health and childbirth, Primary sub-specialty: Reproductive and sexual medicineUKCRC code/ Disease:Pregnancy and Childbirth
ISRCTN98260309The University of Manchester385
Completed
Not Applicable
eurodevelopmental Outcome after Fetal Neonatal Alloimmune Thrombocytopeniaantibodies against platelets during pregnancy.Fetal neonatal alloimmune thrombocytopenia (FNAIT)100355341001684910012562
NL-OMON49430eids Universitair Medisch Centrum63
Recruiting
Not Applicable
European Newborn Study: Early Markers for a Better LifEcerebral palsy10010335
NL-OMON53431niversitair Medisch Centrum Utrecht240